BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $50.00

BrightSpring Health Services (NASDAQ:BTSG) had its price target hoisted by Mizuho from $45.00 to $50.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Several other brokerages also recently commented on BTSG. Cantor Fitzgerald set a $49.00 price objective on BrightSpring Health Services in a research report on Monday. Weiss Ratings reiterated a “hold (c)” rating on shares of BrightSpring Health Services in a research report on Monday, December 29th. BMO Capital Markets restated an “outperform” rating and set a $46.00 target price on shares of BrightSpring Health Services in a research report on Friday, January 23rd. KeyCorp raised shares of BrightSpring Health Services from a “sector weight” rating to an “overweight” rating and set a $45.00 target price for the company in a research note on Friday, December 12th. Finally, Stephens initiated coverage on shares of BrightSpring Health Services in a report on Wednesday, December 10th. They issued an “overweight” rating and a $44.00 price target on the stock. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $44.08.

BrightSpring Health Services Stock Performance

BTSG opened at $41.77 on Tuesday. The firm has a market cap of $8.08 billion, a P/E ratio of 47.47, a PEG ratio of 0.57 and a beta of 2.31. BrightSpring Health Services has a 1-year low of $15.48 and a 1-year high of $44.87. The company has a 50 day simple moving average of $39.42 and a two-hundred day simple moving average of $33.78. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.57 and a quick ratio of 1.12.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings data on Friday, February 27th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.01). The firm had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The firm’s revenue for the quarter was up 29.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.11 earnings per share. Equities analysts forecast that BrightSpring Health Services will post 0.59 earnings per share for the current fiscal year.

Institutional Trading of BrightSpring Health Services

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in BrightSpring Health Services by 30.5% in the fourth quarter. Vanguard Group Inc. now owns 12,533,656 shares of the company’s stock worth $469,385,000 after acquiring an additional 2,928,953 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of BrightSpring Health Services by 4.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,662,236 shares of the company’s stock worth $399,302,000 after purchasing an additional 478,436 shares during the period. Invesco Ltd. boosted its holdings in shares of BrightSpring Health Services by 13.4% in the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock worth $396,791,000 after purchasing an additional 1,248,107 shares during the period. T. Rowe Price Investment Management Inc. increased its position in shares of BrightSpring Health Services by 21.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,123,865 shares of the company’s stock valued at $229,339,000 after purchasing an additional 1,091,757 shares during the last quarter. Finally, Alliancebernstein L.P. raised its holdings in BrightSpring Health Services by 12.1% during the 2nd quarter. Alliancebernstein L.P. now owns 5,450,085 shares of the company’s stock valued at $128,568,000 after buying an additional 588,642 shares during the period.

BrightSpring Health Services News Summary

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Morgan Stanley raised its price target to $48 and kept an “overweight” rating, signaling analyst conviction and around mid-teens upside to recent levels. Article Title
• Positive Sentiment: Wells Fargo increased its price target to $50, another high-profile price-target lift that supports further upside expectations. Article Title
• Positive Sentiment: Zacks upgraded BTSG to a “Strong Buy” (Rank #1) and published multiple pieces noting momentum, inclusion on growth/momentum lists, and upward earnings-estimate revisions — all can attract buyers and algos. Article Title
• Positive Sentiment: Mizuho and other outlets flagged strong upside potential and noted elevated trading volume after analyst coverage changes — higher attention/liquidity can amplify moves. Article Title
• Neutral Sentiment: Several Zacks pieces compare BTSG favorably to peers and highlight it as a fast-moving value/momentum candidate; useful context but not a direct catalyst by itself. Article Title
• Neutral Sentiment: Short-interest reports in the feed show zero shares / NaN changes (data appears erroneous or not meaningful) — no reliable short-squeeze signal at present.
• Negative Sentiment: Most-recent quarterly results included a very slight EPS miss ($0.33 vs. $0.34 consensus) despite a revenue beat and strong year-over-year revenue growth; minor near-term headline risk for short-term traders.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.